About Cephalon, Inc.

Cephalon has a handful of powerful specialty drugs. The company's research, development, manufacturing, and marketing activities focus on therapies for central nervous system (CNS) disorders, cancer, pain, and inflammatory disease. Its NUVIGIL and PROVIGIL drugs treat the sleep disorder narcolepsy. The company's other top sellers are cancer drug TREANDA, cancer pain medications ACTIQ and FENTORA, epilepsy treatment GABITRIL, and muscle relaxant AMRIX. Its eight major products are primarily sold in the US and Europe. Cephalon was acquired by top generic drugmaker Teva Pharmaceutical Industries in 2011.

Company News and Press Releases

- Show Less + Show More News and Press Releases

Cephalon, Inc.

41 Moores Rd
Malvern, PA 19355-1113
Phone: 1 (610) 344-0200
Fax: 1 (610) 738-6590

Stats

  • Employer Type: Subsidiary
  • Chief Financial Officer Executive Vice President: J Kevin Buchi
  • Senior Management (Senior Vice President General Manager Director): Joseph Caminiti
  • Executive Vice President Worldwide Technical Operations: Peter E Grebow
  • Employees: 3,726

Major Office Locations

  • Malvern, PA

Other Locations

  • West Chester, PA
  • Salt Lake City, UT